Literature DB >> 6738855

Psychopathometric demonstration and quantification of mental disturbances following myelography with metrizamide and iopamidol.

G Galle, W Huk, K Arnold.   

Abstract

Groups each consisting of ten patients underwent lumbar and cervical myelography with metrizamide and iopamidol, together with a control group of ten patients who underwent lumbar punctures only. These groups were studied with a psychopathometric test procedure in order to demonstrate and quantify mental disturbances. It was shown that in contrast to myelography with iopamidol, mild mental disturbances are common after myelography with metrizamide. The severity of the mental disturbances after myelography with metrizamide was dependent on the quantity of contrast medium which diffused into the intracranial space after myelography, suggesting a dose-related neurotoxic effect of this substance. Such a correlation was not found with iopamidol.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6738855     DOI: 10.1007/BF00342419

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  15 in total

1.  Subclinical organic psychosyndromes on intrathecal injection of metrizamide for lumbar myelography.

Authors:  S Richert; K Sartor; B Holl
Journal:  Neuroradiology       Date:  1979-10-31       Impact factor: 2.804

2.  Excitation and depression of non-anaesthetized rabbits following injection of contrast media into the subarachnoid space.

Authors:  K Golman; H Olivecrona; C Gustafson; S Salvesen; T Almén; P Maly
Journal:  Acta Radiol Suppl       Date:  1980

3.  Iopamidol, a new non-ionic hydrosoluble contrast medium for neuroradiology.

Authors:  B Hammer; W Lackner
Journal:  Neuroradiology       Date:  1980-04       Impact factor: 2.804

4.  [Lumbosacral radiculography (myelography) (author's transl)].

Authors:  B Hammer
Journal:  Radiologe       Date:  1980-10       Impact factor: 0.635

5.  Cervical myelography with iopamidolo.

Authors:  G Belloni; G Bonaldi; L Moschini; N Quilici
Journal:  Neuroradiology       Date:  1981-03       Impact factor: 2.804

6.  EEG disturbances following myelography, cisternography and ventriculography with metrizamide.

Authors:  A Lundervold; O Sortland
Journal:  Acta Radiol Suppl       Date:  1977

7.  Metrizamide brain penetrance.

Authors:  B P Drayer; A E Rosenbaum
Journal:  Acta Radiol Suppl       Date:  1977

8.  Myelography with iopamidol, a nonionic water-soluble contrast medium: incidence of complications.

Authors:  P Bassi; A Cecchini; P Dettori; E Signorini
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

9.  Iopamidol vs metrizamide: a double blind study for cervical myelography.

Authors:  B P Drayer; M A Warner; A Sudilovsky; J Luther; R Wilkins; S Allen; M Bates
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

10.  A randomized blind trial of iopamidol (Niopam) and Metrizamide (Amipaque) in lumber radiculography.

Authors:  V L McAllister; K Hall
Journal:  Neuroradiology       Date:  1983       Impact factor: 2.804

View more
  3 in total

1.  Influence of the spread and period of retention of Iotrolan in the subarachnoid space on the side effects rate in myelography.

Authors:  B Hoffmann; H Becker; B I Wenzel-Hora
Journal:  Neuroradiology       Date:  1987       Impact factor: 2.804

2.  Lumbar myelography with iopamidol: a methodological approach to the investigation of side effects.

Authors:  L Provinciali; M Signorino; A R Giovagnoli; M Baroni; F Angeleri; U Salvolini; U Pasquini; M Porta; A Judice; R Cerutti
Journal:  Neuroradiology       Date:  1988       Impact factor: 2.804

3.  Electrophysiological and cognitive effects of lumbar myelography with iopamidol: comparison with diagnostic lumbar puncture.

Authors:  L Provinciali; M G Ceravolo; M Signorino; M Baroni; U Pasquini; R Cerrutti; U Salvolini
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.